Dr. Rasmi Palassery, an associate professor in the Department of Medical Oncology, Hematology, and Bone Transplant at Ramaiah Medical College in Bangalore, India. Dr. Palassery shared critical information regarding infections in children following bone marrow transplantation.

The Vulnerability of a Replaced Immune System:

Dr. Palassery explained that children who undergo bone marrow transplantation are highly susceptible to various infections. This is due to a new, developing immune system and the use of immunosuppressant medications. Infections can range from localized issues affecting specific organs (like the brain, sinuses, gut, or skin) to more severe systemic infections where bacteria, viruses, or fungi enter the bloodstream, leading to conditions like bacteremia and potentially life-threatening sepsis.

Prompt Diagnosis: The Key to Early Intervention:

Diagnosing infections in these vulnerable patients requires vigilance. Fever (any temperature above 100.5°F) is a crucial warning sign, especially in the first few months post-transplant, and is treated very seriously. Upon suspicion of infection, broad-spectrum antimicrobials (antibiotics, antivirals, antifungals) are initiated immediately while awaiting definitive diagnosis.

Diagnostic methods include:

• Culturing: Growing organisms from blood or body fluids in a lab.
• Molecular Techniques: Using PCR to identify DNA or genetic material of organisms, particularly viruses, from various samples like blood, urine, nasal secretions, or biopsy.
• Imaging: Utilizing X-rays, CT scans, or MRIs to pinpoint the location of infections, especially in cases of pneumonia, meningitis, or deep abdominal infections. Early imaging is critical compared to the general population.

Aggressive Treatment and Immune Augmentation:

Treatment for these infections is preemptive and aggressive, utilizing a range of injectable and oral antimicrobials. Dr. Palassery highlighted the strategy of “overtreating rather than undertreating” initially to control infections early.

Beyond antimicrobials, sometimes the immune system itself is augmented using cellular therapies. For instance, cytotoxic T-lymphocytes can be engineered in a lab to specifically target and attack certain viruses, offering a potent alternative, especially when antimicrobial resistance is a concern.

Prevention: The Forefront of Post-Transplant Care:

Infection prevention is paramount, particularly in low to middle-income countries where infections are a major cause of mortality after transplant. Key preventive measures include:

• Rigorous Hand Hygiene: Emphasizing proper and frequent hand washing for caregivers and children, especially when handling central venous catheters (lines inserted into major blood vessels for easy access).
• Skin Hygiene: Meticulous attention to bathing and keeping sensitive areas like genitals and underarms clean.
• Environmental Avoidance: Steering clear of crowded spaces and individuals who are ill.
• Vaccine Awareness: Avoiding contact with live vaccines (like those for chickenpox or measles) in siblings or others close to the child, as even inactivated viruses can cause infection in an immunocompromised child.

What to Do if an Infection is Suspected:

Dr. Palassery stressed the importance of immediate action if an infection is suspected. Most transplant centers have an emergency contact system. Any fever should prompt an immediate call to the transplant team or, in settings where communication might be difficult, prompt travel to the hospital while informing the team en route.

She emphasized the “golden hour” for administering the first dose of antibiotics. Caregivers are also educated to recognize other specific symptoms like breathing difficulties, persistent cough or loose stools, repeated vomiting, severe headaches (suggesting meningitis), or growing skin redness, all of which warrant immediate medical attention.

This comprehensive approach to diagnosis, treatment, and prevention is crucial for safeguarding the health of children after bone marrow transplantation.